Related Experiment Video
Updated: Jun 10, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
[Specificities of neonatal hemostasis and implications in pathologic situations]
1Service d'Hématologie-Hémostase, Hôpital Trousseau, 37044 Tours cedex 9, France. gruel@med.univ-tours.fr
Summary
Neonatal hemostasis differs from adults but is prone to bleeding and clotting disorders. Early diagnosis and understanding of fetal hemostasis development are crucial for effective treatment of these conditions in newborns.
Area of Science:
- Hematology
- Neonatology
- Pediatric Thrombosis and Hemostasis
Context:
- Neonatal hemostasis exhibits unique characteristics distinct from adult hemostasis.
- This delicate balance is susceptible to acquired or inherited hemostasis disorders.
- Established reference ranges for hemostatic components in fetuses, newborns, and children aid understanding.
Purpose:
- To review the fetal development of hemostasis up to birth.
- To explore the pathophysiology, diagnosis, and treatment of neonatal bleeding disorders.
- To highlight age-related hemostatic particularities impacting neonatal health.
Summary:
- Healthy newborns possess a balanced hemostatic system, yet it is unstable and vulnerable to disorders.
- Specific conditions like neonatal alloimmune thrombocytopenia and vitamin K deficiency bleeding illustrate age-related risks.
- Diagnosing inherited deficiencies and managing thrombotic events or antithrombotic therapies require consideration of neonatal hemostatic specificities.
Impact:
- Improved understanding of neonatal hemostasis contributes to better diagnosis and management of hemorrhagic and thrombotic disorders.
- Knowledge of fetal hemostasis development informs strategies for preventing and treating neonatal bleeding complications.
- This review provides insights into the unique challenges and considerations for treating hemostatic disorders in neonates.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...